SEARCH RESULT

Total Matching Records found : 9389

Gujarat 2002 and Modi’s Misdeeds by Anand Teltumbde

Ten years after the killings in Gujarat, Narendra Modi has neither expressed regret nor has he been held accountable for those mass deaths. Where do we go from here? Anand Teltumbde (tanandraj@gmail.com) is a writer and civil rights activist with the Committee for the Protection of Democratic Rights, Mumbai.   Just thinking of it, a shiver runs down my spine. I had my own brush with how the Hindutva gangs carried out the...

More »

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Govt uses special powers to slash cancer drug price by 97%-Rupali Mukherjee

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...

More »

India's patent ruling on cancer may open door for cheaper HIV drugs

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

More »

The Dangerous Myths of Fukushima-Joseph Mangano and Janette Sherman

The myth that Fukushima radiation levels were too low to harm humans persists, a year after the meltdown.  A March 2, 2012 New York Times article quoted Vanderbilt University professor John Boice: “there’s no opportunity for conducting epidemiological studies that have any chance for success – the doses are just too low.”  Wolfgang Weiss of the UN Scientific Committee on the Effects of Atomic Radiation also recently said doses observed...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close